Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer-Reference-Cited by-同舟云学术

Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer

Published:2011-04-15 Issue:10 Volume:17 Page:3455-3468
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Deenen Maarten J.,Tol Jolien,Burylo Artur M,Doodeman Valerie D.,de Boer Anthonius,Vincent Andrew,Guchelaar Henk-Jan,Smits Paul H.M.,Beijnen Jos H.,Punt Cornelis J.A.,Schellens Jan H.M.,Cats Annemieke

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MIR27A Gene Polymorphism Modifies the Effect of Common DPYD Gene Variants on Severe Toxicity in Patients with Gastrointestinal Tumors Treated with Fluoropyrimidine-Based Anticancer Therapy;International Journal of Molecular Sciences;2024-08-04

2. Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study;Pharmaceutics;2024-07-19

3. Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis;British Journal of Cancer;2024-01-15

4. Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies;Cell Reports Medicine;2023-12

5. Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments;Cancers;2023-09-22